Medicamen Biotech Limited

NSE MEDICAMEQ.NS

Medicamen Biotech Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2024: USD 756.93 K

Medicamen Biotech Limited Net Cash Used Provided By Financing Activities is USD 756.93 K for the year ending March 31, 2024, a -78.64% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Medicamen Biotech Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2023 was USD 3.54 M, a 526.10% change year over year.
Medicamen Biotech Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2022 was USD 566.03 K, a -29.02% change year over year.
Medicamen Biotech Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2021 was USD 797.42 K, a -68.48% change year over year.
Medicamen Biotech Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2020 was USD 2.53 M, a 576.43% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

NSE: MEDICAMEQ.NS

Medicamen Biotech Limited

CEO	Mr. Rajesh Madan B. Pharma
IPO Date	Oct. 27, 2021
Location	India
Headquarters	1506, Chiranjiv Tower
Employees	378
Sector	Consumers Staples
Industries Personal Care Cleaning Supplies Cosmetics Dental Care Drugstores & Retail Pharmacies Eyewear Non-Alcoholic Beverages Pharmaceuticals

Description

Medicamen Biotech Limited manufactures and sells pharmaceutical formulations in India. The company offers its products in various forms, including tablets, capsules, liquid and dry syrups, and ointments. It also provides oral rehydration solution, mouth wash, and dental care products. The company was incorporated in 1993 and is based in New Delhi, India.

Key trends

Past 5 years